SAN || Expert Analysis

VIDEO: How the latest topical antifungals are working for patients

Posted on: 30/10/2014 - 21:13

LAS VEGAS – The latest topical treatments “are going to change the way we treat onychomycosis,” Dr. David Pariser said at the Skin Disease Education Foundation’s annual Las Vegas dermatology...

Field of Interest: Dermatology

Type: News Item

New onychomycosis drugs show similar success and side effects

Posted on: 30/10/2014 - 16:00

LAS VEGAS – The latest topical therapies for onychomycosis are strong enough to penetrate nail polish, but patients report few side effects. “New topical antifungals have improved the challenge of...

Field of Interest: Dermatology

Type: News Item

Select biologics for dose escalation in psoriasis

Posted on: 22/10/2014 - 15:58

SONOMA, CALIF.– Data support dosage escalation or intensification for patients who don’t respond to biologic therapy for psoriasis, but only for three of the four biologic agents available in the...

Field of Interest: Dermatology

Type: News Item

VIDEO: Dr. Alan Menter discusses apremilast’s approval for psoriasis

Posted on: 14/10/2014 - 15:09

NEWPORT BEACH, CALIF. – The approval of apremilast (Otezla) for the treatment of moderate to severe plaque psoriasis will make a significant impact on patient care, Dr. Alan Menter of Baylor...

Field of Interest: Dermatology

Type: News Item

Look to presentation, not pathology, for dermatomyositis diagnosis

Posted on: 29/09/2014 - 15:13

VANCOUVER, B.C.– On histology, pathologists are unable to reliably differentiate between cutaneous lupus erythematosus and dermatomyositis. So it falls to clinicians to sort out what’s what based on...

Field of Interest: Dermatology

Type: News Item

Look to presentation, not pathology, for dermatomyositis diagnosis

Posted on: 29/09/2014 - 15:13

Field of Interest: Rheumatology

Type: News Item

Uncertainty remains over importance of subtle hydroxychloroquine eye changes

Posted on: 26/09/2014 - 16:46

LAS VEGAS– With the help of newer equipment, ophthalmologists are catching hydroxychloroquine-associated retina changes earlier than ever before, but it’s not clear if early changes signal trouble...

Field of Interest: Rheumatology

Type: News Item

Rethink using single-envelope CFLs in photosensitive patients

Posted on: 17/09/2014 - 14:15

EDINBURGH – Physicians may want to avoid exposing their photosensitive patients to single-envelope compact fluorescent lamps. Better to use the double-envelope variety, Dr. Harry Moseley suggested....

Field of Interest: Dermatology

Type: News Item

Consider a zero therapy approach to periorificial dermatitis

Posted on: 25/08/2014 - 20:55

CHICAGO – For periorificial dermatitis, don’t do a thing. That was the first-line therapy suggested at this year’s American Academy of Dermatology summer meeting. "Sometimes you have to be...

Field of Interest: Dermatology

Type: News Item

Mobile teledermatology predicted to be a game changer

Posted on: 11/08/2014 - 18:30

COEUR D’ALENE, IDAHO – Teledermatology is gathering steam – and supportive data – as a potentially invaluable way to address the overlapping problems of a dermatology workforce shortage, gruelingly...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters